Antibiotic treatment during early childhood and risk of type 1 diabetes in children: A national birth cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Antibiotic treatment during early childhood and risk of type 1 diabetes in children : A national birth cohort study. / Antvorskov, Julie Christine; Morgen, Camilla Schmidt; Buschard, Karsten; Jess, Tine; Allin, Kristine Højgaard; Josefsen, Knud.

I: Pediatric Diabetes, Bind 21, Nr. 8, 2020, s. 1457-1464.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Antvorskov, JC, Morgen, CS, Buschard, K, Jess, T, Allin, KH & Josefsen, K 2020, 'Antibiotic treatment during early childhood and risk of type 1 diabetes in children: A national birth cohort study', Pediatric Diabetes, bind 21, nr. 8, s. 1457-1464. https://doi.org/10.1111/pedi.13111

APA

Antvorskov, J. C., Morgen, C. S., Buschard, K., Jess, T., Allin, K. H., & Josefsen, K. (2020). Antibiotic treatment during early childhood and risk of type 1 diabetes in children: A national birth cohort study. Pediatric Diabetes, 21(8), 1457-1464. https://doi.org/10.1111/pedi.13111

Vancouver

Antvorskov JC, Morgen CS, Buschard K, Jess T, Allin KH, Josefsen K. Antibiotic treatment during early childhood and risk of type 1 diabetes in children: A national birth cohort study. Pediatric Diabetes. 2020;21(8):1457-1464. https://doi.org/10.1111/pedi.13111

Author

Antvorskov, Julie Christine ; Morgen, Camilla Schmidt ; Buschard, Karsten ; Jess, Tine ; Allin, Kristine Højgaard ; Josefsen, Knud. / Antibiotic treatment during early childhood and risk of type 1 diabetes in children : A national birth cohort study. I: Pediatric Diabetes. 2020 ; Bind 21, Nr. 8. s. 1457-1464.

Bibtex

@article{43720acdb56c4afba9f329e9f2db51a3,
title = "Antibiotic treatment during early childhood and risk of type 1 diabetes in children: A national birth cohort study",
abstract = "Objective/Background: Antibiotics are widely used during childhood infections and influence the composition of the microbiota, which is established during the first years of life. Evidence from animal models of type 1 diabetes shows that antibiotics might accelerate disease progression, and altered intestinal microbiota has been reported in association with type 1 diabetes in humans. We aimed to test the hypothesis that early exposure to antibiotics (0-24 months of age) was associated with an increased risk of childhood type 1 diabetes development. Methods: We studied 75 615 mother-child dyads from the Danish National Birth Cohort. Information on the use of antibiotics during early childhood and type 1 diabetes development in childhood was available for all children via linkage to the Danish National Prescription Registry and the Danish National Patient Register, respectively. The mean follow-up time was 14.3 years (range 11.5 to 18.4 years, SD 1.4). Results: After adjustment for confounders, we found no association between antibiotic exposure and risk of type 1 diabetes (HR 1.26, 95% CI 0.89-1.79). The number of antibiotic courses during early childhood was not associated with type 1 diabetes development when analyzing for one (HR 1.31, 95% CI 0.87-1.99), two (HR 0.99, 95% CI 0.61-1.63), or 3 or more (HR 1.42, 95% CI 0.95-2.11) courses. Furthermore, no specific types of antibiotics (penicillins/beta-lactam antibacterials, sulfonamide/trimethroprim, or macrolides/lincosamides/streptogramins) were associated with increased risk of type 1 diabetes. Conclusion: Our nationwide cohort study suggests that postnatal exposure to antibiotics does not influence the development of childhood type 1 diabetes.",
keywords = "antibiotics, children, early childhood, postnatal exposure, type 1 diabetes",
author = "Antvorskov, {Julie Christine} and Morgen, {Camilla Schmidt} and Karsten Buschard and Tine Jess and Allin, {Kristine H{\o}jgaard} and Knud Josefsen",
year = "2020",
doi = "10.1111/pedi.13111",
language = "English",
volume = "21",
pages = "1457--1464",
journal = "Pediatric Diabetes",
issn = "1399-543X",
publisher = "Wiley-Blackwell",
number = "8",

}

RIS

TY - JOUR

T1 - Antibiotic treatment during early childhood and risk of type 1 diabetes in children

T2 - A national birth cohort study

AU - Antvorskov, Julie Christine

AU - Morgen, Camilla Schmidt

AU - Buschard, Karsten

AU - Jess, Tine

AU - Allin, Kristine Højgaard

AU - Josefsen, Knud

PY - 2020

Y1 - 2020

N2 - Objective/Background: Antibiotics are widely used during childhood infections and influence the composition of the microbiota, which is established during the first years of life. Evidence from animal models of type 1 diabetes shows that antibiotics might accelerate disease progression, and altered intestinal microbiota has been reported in association with type 1 diabetes in humans. We aimed to test the hypothesis that early exposure to antibiotics (0-24 months of age) was associated with an increased risk of childhood type 1 diabetes development. Methods: We studied 75 615 mother-child dyads from the Danish National Birth Cohort. Information on the use of antibiotics during early childhood and type 1 diabetes development in childhood was available for all children via linkage to the Danish National Prescription Registry and the Danish National Patient Register, respectively. The mean follow-up time was 14.3 years (range 11.5 to 18.4 years, SD 1.4). Results: After adjustment for confounders, we found no association between antibiotic exposure and risk of type 1 diabetes (HR 1.26, 95% CI 0.89-1.79). The number of antibiotic courses during early childhood was not associated with type 1 diabetes development when analyzing for one (HR 1.31, 95% CI 0.87-1.99), two (HR 0.99, 95% CI 0.61-1.63), or 3 or more (HR 1.42, 95% CI 0.95-2.11) courses. Furthermore, no specific types of antibiotics (penicillins/beta-lactam antibacterials, sulfonamide/trimethroprim, or macrolides/lincosamides/streptogramins) were associated with increased risk of type 1 diabetes. Conclusion: Our nationwide cohort study suggests that postnatal exposure to antibiotics does not influence the development of childhood type 1 diabetes.

AB - Objective/Background: Antibiotics are widely used during childhood infections and influence the composition of the microbiota, which is established during the first years of life. Evidence from animal models of type 1 diabetes shows that antibiotics might accelerate disease progression, and altered intestinal microbiota has been reported in association with type 1 diabetes in humans. We aimed to test the hypothesis that early exposure to antibiotics (0-24 months of age) was associated with an increased risk of childhood type 1 diabetes development. Methods: We studied 75 615 mother-child dyads from the Danish National Birth Cohort. Information on the use of antibiotics during early childhood and type 1 diabetes development in childhood was available for all children via linkage to the Danish National Prescription Registry and the Danish National Patient Register, respectively. The mean follow-up time was 14.3 years (range 11.5 to 18.4 years, SD 1.4). Results: After adjustment for confounders, we found no association between antibiotic exposure and risk of type 1 diabetes (HR 1.26, 95% CI 0.89-1.79). The number of antibiotic courses during early childhood was not associated with type 1 diabetes development when analyzing for one (HR 1.31, 95% CI 0.87-1.99), two (HR 0.99, 95% CI 0.61-1.63), or 3 or more (HR 1.42, 95% CI 0.95-2.11) courses. Furthermore, no specific types of antibiotics (penicillins/beta-lactam antibacterials, sulfonamide/trimethroprim, or macrolides/lincosamides/streptogramins) were associated with increased risk of type 1 diabetes. Conclusion: Our nationwide cohort study suggests that postnatal exposure to antibiotics does not influence the development of childhood type 1 diabetes.

KW - antibiotics

KW - children

KW - early childhood

KW - postnatal exposure

KW - type 1 diabetes

U2 - 10.1111/pedi.13111

DO - 10.1111/pedi.13111

M3 - Journal article

C2 - 32902076

AN - SCOPUS:85091780623

VL - 21

SP - 1457

EP - 1464

JO - Pediatric Diabetes

JF - Pediatric Diabetes

SN - 1399-543X

IS - 8

ER -

ID: 249857031